Accumulating evidence has indicated that NUCB2/nesfatin‐1 expression was upregulated in cancer tissues compared to the noncancerous tissues obtained from the same patient in various tumours including colon cancer,10 prostate cancer,19 endometrial cancer11 and papillary thyroid cancer.12 The gene discussed is NUCB2; the disease is cancer.